Tim Anderson
Tim Anderson
Timothy Devon Andersonis an American professional baseball shortstop for the Chicago White Sox of Major League Baseball. Anderson played college baseball at East Central Community College, and was selected in the first round of the 2013 MLB draft by the White Sox. He made his MLB debut on June 10, 2016...
ProfessionBaseball Player
Date of Birth23 June 1993
good negative people quarter time wary
The quarter was good in that they didn't have anything negative at a time when a lot of people are wary about earnings,
earnings growth guidance revenue seems tells
Merck tells an interesting story, yet the five-year revenue and earnings growth guidance seems far-fetched.
beat company earnings key sale several
While the company beat earnings (expectations), sale for several key franchises lagged our estimates.
aware choice curious describe differ driving exceeded factors investors language performance pleased previous saying sure using
Pfizer is using curious language to describe 2006, saying 'while we are pleased that 2005 exceeded previous expectations, investors should be aware that the factors driving performance may differ materially in 2006. We are not sure what to make of this choice of words.
benefits move proof pudding
The proof of the pudding will be what are the benefits at the checkpoint. Will you be able to move through faster? If so, I think this will be a very well-received program.
difficulty raising reached stock target
The stock has reached our target of $44 and we have difficulty raising it much from here.
forward good looks moves moving
Anything that moves it forward is a good thing, and this looks like it's moving forward.
burnt fortune good great hole knocking last putt
I had the good fortune of knocking my 2-3-foot putt in on the last hole and Doug's just burnt the edge. He was a great competitor.
addition goes homes single taken technician
In addition to that, he does not go into customers' homes alone. I have another technician that goes with him on every single job. We've taken precautions.
coming convert depends few generation next people quarters second shoes visibility
Schering will be coming out with a second generation (Claritin) drug in the next few months, so it depends how many people they convert (to the new drug), ... They could be in Merck's shoes a few quarters from now, but I don't think they have the visibility to say.
biggest deals hurdle issues management run
The biggest hurdle in deals like these is the management issues - who will run the company.
action again based beat clearly credit deserves equity higher increased investors itself starting strong taking together
The beat was based on a combination of strong top-line growth, increased equity income, and higher other revenue. Merck deserves credit for starting to take action to put itself back together again and investors are clearly taking up the story.
bad good quarter quiet
It was a good quarter and quiet with no surprises, which is never a bad thing.
great pro
It's a great following. It's our pro sport.